{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:37:30Z","timestamp":1785598650178,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["21FC1008"],"award-info":[{"award-number":["21FC1008"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.thromres.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T02:15:49Z","timestamp":1646878549000},"page":"154-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: A single-center analysis"],"prefix":"10.1016","volume":"213","author":[{"given":"Tsukasa","family":"Osaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2022.03.006_bb0005","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.thromres.2022.03.006_bb0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1055\/s-0037-1614361","article-title":"Rare coagulation disorders","volume":"82","author":"Peyvandi","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/07853890.2011.576698","article-title":"Inherited disorders of blood coagulation","volume":"44","author":"Lippi","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.thromres.2022.03.006_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1182\/hematology.2019000066","article-title":"Management of rare acquired bleeding disorders","volume":"2019","author":"Menegatti","year":"2019","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.thromres.2022.03.006_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF02737641","article-title":"Autoantibodies to coagulation factors and bleeding disorders","volume":"16","author":"Ahmed","year":"1998","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00062752-199909000-00009","article-title":"Acquired autoantibodies to coagulation factors","volume":"6","author":"Macik","year":"1999","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2022.03.006_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2013.08.001","article-title":"Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy","volume":"13","author":"Cugno","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2022.03.006_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.08.002","article-title":"Japanese Collaborative Research Group on AH13. Autoimmune acquired factor XIII deficiency due to anti-factor XIII\/13 antibodies: a summary of 93 patients","volume":"31","author":"Ichinose","year":"2017","journal-title":"Blood Rev."},{"issue":"3","key":"10.1016\/j.thromres.2022.03.006_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/a-1496-8527","article-title":"Autoimmune coagulation factor X deficiency as a rare acquired hemorrhagic disorder: a literature review","volume":"122","author":"Ichinose","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.me.20.020169.000431","article-title":"Acquired inhibitors of coagulants","volume":"20","author":"Bidwell","year":"1969","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.thromres.2022.03.006_bb0060","first-page":"75","article-title":"Acquired inhibitors of blood coagulation","volume":"1","author":"Feinstein","year":"1972","journal-title":"Prog. Hemost. Thromb."},{"key":"10.1016\/j.thromres.2022.03.006_bb0065","first-page":"65","article-title":"Acquired inhibitors in nonhemophilic patients","volume":"3","author":"Lechner","year":"1974","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2022.03.006_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0950-3536(96)80067-9","article-title":"Acquired inhibitors","volume":"9","author":"Cohen","year":"1996","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002770050305","article-title":"Inhibitors to clotting factors","volume":"75","author":"Sallah","year":"1997","journal-title":"Ann. Hematol."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.03.006_bb0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2257.2000.00001.x","article-title":"Spontaneous inhibitors to coagulation factors","volume":"22","author":"Green","year":"2000","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0032-1305779","article-title":"Acquired inhibitors of coagulation factors: part II","volume":"38","author":"Franchini","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0090","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bjh.12463","article-title":"United KingdomHaemophilia Centre Doctors' Organization. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO","volume":"162","author":"Collins","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0095","first-page":"498","article-title":"AICE Working Group. Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management","volume":"13","author":"Franchini","year":"2015","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2022.03.006_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAT.0b013e328353254d","article-title":"Laboratory identification of factor inhibitors: an update","volume":"44","author":"Kershaw","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.thromres.2022.03.006_bb0105","first-page":"667","article-title":"Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management","volume":"60","author":"Ichinose","year":"2019","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.thromres.2022.03.006_bb0110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1160\/TH16-05-0362","article-title":"Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Recommendation for ISTH\/SSC Criterion 2015 for autoimmune acquired factor XIII\/13 deficiency","volume":"116","author":"Ichinose","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12185-018-2561-9","article-title":"A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis","volume":"109","author":"Ogawa","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4657501","article-title":"Autoimmune factor V deficiency that took 16 years to diagnose due to pseudodeficiency of multiple coagulation factors","volume":"2021","author":"Kato","year":"2021","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.thromres.2022.03.006_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/hae.14298","article-title":"Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies","volume":"27","author":"Ichinose","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2022.03.006_bb0130","first-page":"869","article-title":"A more uniform measurement of factor VIII-inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb. Diath. Haemorrh."},{"key":"10.1016\/j.thromres.2022.03.006_bb0135","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1182\/blood.V63.6.1309.1309","article-title":"A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus","volume":"63","author":"Poon","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.03.006_bb0140","first-page":"199","article-title":"Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients","volume":"18","author":"Horellou","year":"1987","journal-title":"J. Med."},{"key":"10.1016\/j.thromres.2022.03.006_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijlh.13335","article-title":"Impact of variation in reagent combinations for one-stage clotting assay on assay discrepancy in nonsevere haemophilia A","volume":"43","author":"Suzuki","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0150","first-page":"255","article-title":"Coagulation factor V inhibitor negative, non-neutralizing anti-factor V antibody positive autoimmune acquired factor V deficiency","volume":"31","author":"Kaneda","year":"2020","journal-title":"Jpn. J. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.thromres.2016.09.013","article-title":"Transient factor V deficiency associated with factor V-immunoglobulin complexes but without evidence of a classical inhibitor","volume":"147","author":"Cortier","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2022.03.006_bb0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2020.00563","article-title":"Prevalence and incidence of non-neutralizing antibodies in congenital hemophilia A- a systematic review and meta-analysis","volume":"11","author":"Abdi","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0165","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans","volume":"125","author":"Hofbauer","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.03.006_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-021-03212-9","article-title":"Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan","volume":"115","author":"Ieko","year":"2022","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0175","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1365-2141.1996.d01-1705.x","article-title":"High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII","volume":"93","author":"Dazzi","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2516.2007.01450.x","article-title":"ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay","volume":"13","author":"Sahud","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2022.03.006_bb0185","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1182\/blood-2016-06-720086","article-title":"SIPPET study group. Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A","volume":"129","author":"Cannav\u00f2","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.03.006_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/ejh.12500","article-title":"One-stage vs. chromogenic assays in haemophilia A","volume":"94","author":"Potgieter","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jth.13215","article-title":"A critical appraisal of one-stage and chromogenic assays of factor VIII activity","volume":"14","author":"Peyvandi","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.03.006_bb0200","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1111\/hae.13827","article-title":"Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors","volume":"25","author":"Payne","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2022.03.006_bb0205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ijlh.12877","article-title":"Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B","volume":"40","author":"Adcock","year":"2018","journal-title":"Int. J. Lab. Hem."},{"key":"10.1016\/j.thromres.2022.03.006_bb0210","first-page":"271","article-title":"A chromogenic substrate method for detecting and titrating anti-factor VIII antibodies in the presence of lupus anticoagulant","volume":"87","author":"Blanco","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2022.03.006_bb0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/ijlh.13083","article-title":"Performance evaluation of Revohem \u2122 FVIII chromogenic and Revohem \u2122 FIX chromogenic in the CS-5100 autoanalyser","volume":"41","author":"Suzuki","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2022.03.006_bb0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2169\/internalmedicine.9150-17","article-title":"High titer of acquired factor V inhibitor presenting with a pseudo-deficiency of multiple coagulation factors","volume":"57","author":"Nakata","year":"2018","journal-title":"Intern. Med."},{"key":"10.1016\/j.thromres.2022.03.006_bb0225","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/jth.13304","article-title":"Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01\/2010 study","volume":"14","author":"Werwitzke","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.03.006_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-0041-1740149","article-title":"A review of coagulation abnormalities of autoimmune acquired factor V deficiency with a focus on Japan","volume":"48","author":"Ichinose","year":"2022","journal-title":"Semin. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:48:29Z","timestamp":1758736109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":46,"alternative-id":["S0049384822000822"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.03.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: A single-center analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}